Results 221 to 230 of about 96,603 (330)

Prostatitis syndromes and benign prostatic hyperplasia

Seminars in Roentgenology, 1999
S R, Potter, A W, Partin
openaire   +2 more sources

Nanotechnology‐Enhanced Approaches for Early Cancer Diagnosis

Nano Select, Volume 7, Issue 1, January 2026.
Conventional MRI and PET provide limited sensitivity and contrast for precise brain lesion detection. In contrast, radiolabeled nanoparticlebased PET imaging enables enhanced signal specificity and sensitivity. By integrating multifunctional nanoprobes, this platform improves multimodal imaging performance, allowing more accurate visualization of ...
Jongmoo Lee, Jiyu Kim, Eunhye Cho, Junyeop Jeong, Jayeon Song, Mikyung Kang   +5 more
wiley   +1 more source

A Narrative Review of New Emerging Urological Interventions for Benign Prostatic Hyperplasia: HoLEP, Rezum, and Aquablation. [PDF]

Cureus
Sathish V.
europepmc   +1 more source

Assessing the Safety of Combined Therapy, Croton membranaceus and Tamsulosin, in the Self‐Prescribed Treatment Protocol for Benign Prostatic Hyperplasia [PDF]

Cosmos Gborsong, George Awuku Asare, Robert A. Ngala, Christian Obirikorang, Josephine Ablakwa, Bernice Asiedu, Samuel Adjei, Osei Afriyie, Daniel Kwame Afriyie, Mokbul Hossain, Munmun Pervin, Md. Mahmudul Alam, Mst. Antora Akter, Mohammed Habibur Rahman   +13 more
openalex   +1 more source

Impact of Prostatic Urethral Lift and Water Vapor Energy Therapy on Bladder Outlet Obstruction in Elderly or Comorbid Patients With Benign Prostatic Hyperplasia in Real‐World Clinical Practice

Neurourology and Urodynamics, Volume 45, Issue 1, Page 105-114, January 2026.
ABSTRACT Objective To evaluate the effects of prostatic urethral lift (PUL) and water vapor energy therapy (WAVE) on bladder outlet obstruction (BOO) using pressure flow studies (PFS) in real‐world clinical practice among patients with benign prostatic hyperplasia (BPH), particularly those who are elderly or in poor general health.
Yuki Kyoda, Yoko Saito, Nodoka Kozen, Tetsuya Shindo, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori   +7 more
wiley   +1 more source

Correction to: Hydroxycitric acid inhibits ferroptosis and ameliorates benign prostatic hyperplasia by upregulating the Nrf2/GPX4 pathway. [PDF]

World J Urol
Yang D, Zhai C, Ren J, Bai J, Li T, Lu M, Tang Y, Wei L, Luo R, Tong F.   +9 more
europepmc   +1 more source

Use of dual-phase contrast computed tomography for evaluation of the normal canine male genital tract [PDF]

, 2016
Ali, Atalan, Bjurlin, Black, Drees, Dyce, England, Evans, Furtado, Hanson, Hanyok, Hecht, Hecht, Hicks, Lavely, Lee, Mahapokai, Parker, Ruel, Shen, Suh, Traish, Zohil   +22 more
core   +2 more sources

Is It Necessary to Remove the Maximum Prostate Tissue in All Patients? the Percentage of Resected Prostate Tissue and the Influence on Surgery Outcomes: A One‐Year Follow Up Study

Neurourology and Urodynamics, Volume 45, Issue 1, Page 115-119, January 2026.
ABSTRACT Introduction To investigate whether the volume of the prostate tissue resected on TURP influences on short and medium term follow up. Methods It was developed a prospective study between May 2020 and August 2022, embracing patients with severe LUTS due to BPO, including clinical and urodynamic parameters meeting obstruction criteria (BOOI > 40)
Bruno Rodrigues Lebani, André Barcelos da Silva, Luciano Teixeira Silva, Marcia Eli Girotti, Eduardo Remaile Pinto, Milton Skaff, Fernando Gonçalves Almeida   +6 more
wiley   +1 more source

The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer [PDF]

, 2015
Lu Yang, Liang Gao, Yongji Chen, Zhuang Tang, Yuchun Zhu, Ping Han, Xiang Li, Qiang Wei   +7 more
openalex   +1 more source

PROSTest, a Multigene Liquid Biopsy Signature, Effectively Stratifies Patients With High PSA for Prostate Biopsy

The Prostate, Volume 86, Issue 1, Page 43-52, January 2026.
ABSTRACT Background Prostate‐specific antigen (PSA) remains the standard biomarker for prostate cancer (PCa) detection, but its limited specificity—particularly in the 3–10 ng/mL range—leads to overdiagnosis and unnecessary biopsies. Including multiparameteric MRI (mpMRI) helps to reduce the number of PSA‐false‐positive biopsies, but there is still a ...
Kambiz Rahbar, R. David Rosin, Mark Kidd, Abdel B. Halim, Oliver Sartor   +4 more
wiley   +1 more source